EMA reasserts differences with FDA for Covid vaccine strain selection
The European Medicines Agency (EMA) on Friday reconfirmed that its strain selection for Covid-19 vaccines for the fall season will differ slightly from the FDA’ …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.